TGFB1 and neoplasm: More importantly, integrin αvβ3 can augment TGF-β signaling [20] which has been shown to stimulate the expression of PTHrP by tumor cells and osteoblast expression of RANKL, thereby promoting osteoclast-mediated bone destruction [2,39].